Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The combination of levobupivacaine and sufentanil is used primarily in anesthesia, particularly for spinal and epidural anesthesia. This combination provides effective pain management with several clinical advantages over using either drug alone. ## Pharmacological Properties Levobupivacaine is a local anesthetic agent that blocks the generation and conduction of nerve impulses by increasing the threshold for electrical excitation, slowing nerve impulse propagation, and reducing the rate of rise of the action potential[10]. It's the isolated S(-) isomer of bupivacaine and is less cardiotoxic than racemic bupivacaine according to animal studies[5]. Sufentanil is a potent opioid used to induce and maintain anesthesia, provide analgesia during labor and delivery, and treat severe, acute pain[8]. When combined with levobupivacaine, sufentanil enhances the quality of anesthesia and extends the duration of postoperative analgesia[1]. ## Clinical Applications The combination is commonly used in: - Spinal anesthesia for cesarean section surgery[1] - Transurethral resection of the prostate (TURP)[2][6] - Epidural analgesia after lung surgery[4] - Labor and vaginal delivery[8] ## Clinical Benefits Research shows that combining levobupivacaine with sufentanil provides several advantages: 1. **Faster onset of sensory and motor blocks**: The addition of sufentanil to levobupivacaine allows for rapid onset time for sensory and motor block levels[1][6]. 2. **Extended duration of postoperative analgesia**: The combination extends the duration of postoperative analgesia and reduces the total analgesic requirement compared to levobupivacaine alone[1][6]. 3. **Dose reduction potential**: Lower doses of levobupivacaine can be used when combined with sufentanil while maintaining effective anesthesia[2][6]. 4. **Reduced motor block**: The combination provides lower frequency and shorter duration of motor block compared to levobupivacaine alone[6]. 5. **Hemodynamic stability**: Studies show the combination provides adequate anesthesia with hemodynamic stability, particularly important in elderly patients[2]. ## Side Effects The most commonly reported side effect specific to the combination is pruritus, which occurs more frequently with sufentanil addition[1][2]. Other potential side effects include nausea, vomiting, and sedation, though these occur at similar rates to levobupivacaine alone[5]. The combination of levobupivacaine and sufentanil represents an effective approach for anesthesia and analgesia in various surgical procedures, offering improved onset time, extended duration of action, and reduced motor blockade compared to levobupivacaine alone.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on levobupivacaine + sufentanil.